Dr. George L. McLendon

George McLendon is an educator, research scientist and entrepreneur. Effective August 15, 2015 he became the Vice President – Therapeutic Research and Development at the nation’s largest non-profit health care company, Carolinas HealthCare System.

Previously, he served as Howard Hughes Provost and Professor of Chemistry at Rice University from 2011-2015. He was Dean of Arts and Sciences and Professor of Chemistry and Biochemistry at Duke University and faculty member of the Cancer Center at Duke University Medical School. We was chair of the Department of Chemistry at Princeton University and Professor of Chemistry (School of Arts and Sciences) and Biochemistry (Medical School) at the University of Rochester. He also served as visiting professor at CalTech and Oxford University, where he is a fellow of Worcester College.

He has published over 200 research papers in chemistry, physics and biology and holds multiple patents. His research work has been recognized by multiple awards: including the American Chemical Society’s Pure Chemistry Award, the Eli Lilly award for fundamental research in Biochemistry, and Sloan, Dreyfus, and Guggenheim fellowships. This work was supported by research grants of over $30M from the NIH, NSF and CPRIT. His work contributed to founding several companies including Tetralogic (Oncology, NASDAQ), Steamtrax (Digital Education, acquired by 3D Systems NYSE) and Labcyte (Microfluidics, private equity acquisition). He is a founding co-director of TMCx, the largest accelerator for biomedical startups, and serves on advisory and governing boards for several early-stage life science companies.